Skip to main content
OpenTrials

Clinical trial condition

Chronic Myelomonocytic Leukemia

Explore clinical trials studying Chronic Myelomonocytic Leukemia. Study availability and eligibility vary by location and protocol.

194 public trials 38 recruiting studies
Refine in advanced search Browse all conditions

Chronic Myelomonocytic Leukemia trial results

Completed

Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders

NCT00588991

Conditions
Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia, Adult Acute Monocytic Leukemia, +55 more
Locations
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
View Trial Details
Completed

Tagraxofusp (SL-401) in Participants With Chronic Myelomonocytic Leukemia (CMML) and Myelofibrosis (MF)

NCT02268253

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +14 more
Locations
  • University of California, San Francisco Clovis, California, United States
  • City of Hope Duarte, California, United States
  • University of California, Los Angeles Los Angeles, California, United States
  • Stanford Cancer Institute Stanford, California, United States
View all 24 locations
View Trial Details
Completed

IDH2-Post-Allo-Trial for Patients with IDH2-mut Myeloid Neoplasms After Allo-SCT

NCT04522895

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +16 more
Locations
  • University Hospital Duesseldorf Dept. of Hematology, Oncology and Clinical Immunology Düsseldorf, North Rhine-Westphalia, Germany
  • Uniklinik RWTH Aachen Klinik für Hämatologie, Onkologie, Hämostaseologie und Stammzelltransplantation (Med. Klinik IV) Aachen, Germany
  • Universitätsklinikum Köln Klinik I für Innere Medizin Cologne, Germany
  • Universitätsklinikum Carl Gustav Carus Medizinische Klinik und Poliklinik I Dresden, Germany
View Trial Details
Completed

Study of ASTX727 vs IV Decitabine in Participants With MDS, CMML, and AML

NCT03306264

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +14 more
Locations
  • Pinnacle Research Group Anniston, Alabama, United States
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Arizona Clinical Research Center Tucson, Arizona, United States
  • Compassionate Cancer Care Research Group Fountain Valley, California, United States
View all 84 locations
View Trial Details
Completed

Effect of Food on Blood Levels of ASTX727

NCT03813186

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +14 more
Locations
  • Roswell Park Buffalo, New York, United States
  • Gabrail Cancer Center Canton, Ohio, United States
  • Vanderbilt Nashville, Tennessee, United States
  • Mays Cancer Center UT Health San Antonio MD Anderson Cancer Center San Antonio, Texas, United States
View Trial Details
Completed

Evaluating in Vivo AZA Incorporation in Mononuclear Cells Following Vidaza or CC486

NCT03493646

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +14 more
Locations
  • Calvary Mater Newcastle Newcastle, New South Wales, Australia
  • Nepean Hospital Penrith, New South Wales, Australia
  • Prince of Wales Hospital Sydney, New South Wales, Australia
  • Royal North Shore Hospital Sydney, New South Wales, Australia
View Trial Details
Completed

Registry on Hypomethylating Agents in Myeloid Neoplasms

NCT01595295

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +14 more
Locations
  • LKH Feldkirch, Innere Med. II, Interne E Feldkirch, Austria
  • LKH Fürstenfeld Fürstenfeld, Austria
  • UK Graz: Universitätsklinik für Innere Medizin; Klinische Abteilung für Hämatologie Graz, Austria
  • Universitätsklinik für Innere Medizin V Innsbruck, Austria
View all 20 locations
View Trial Details
Completed

Chemotherapy in Treating Patients With Myelodysplastic Syndrome Before Donor Stem Cell Transplant

NCT01812252

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +15 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Cleveland Clinic Foundation Cleveland, Ohio, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
  • Kaiser Permanente Washington Seattle, Washington, United States
View Trial Details

Related conditions